Literature DB >> 28082497

Complete Genome Sequence of Streptococcus iniae UEL-Si1, Isolated in Diseased Nile Tilapia (Oreochromis niloticus) from Northern Paraná, Southern Brazil.

Laurival A Vilas-Boas1, Selwyn A Headley2, Kátia B Gonçalves, Josiane A Scarpassa3, Lucienne G Pretto-Giordano2.   

Abstract

The Streptococcus iniae UEL-Si1 strain was isolated from diseased Nile tilapia within the Paranapanema River Basin, Northern Paraná, Brazil. This is an emerging infectious disease agent of fish from Brazil, and sequencing of the complete genome is fundamental to understanding aspects relative to pathogenesis, infection, epidemiology, and immunity.
Copyright © 2017 Vilas-Boas et al.

Entities:  

Year:  2017        PMID: 28082497      PMCID: PMC5256207          DOI: 10.1128/genomeA.01458-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus iniae is a Gram-positive bacterium that was first identified from the freshwater dolphin, Inia geoffrensis, in association with golf ball disease (1). The first description of S. iniae as a human pathogen occurred in 1996 in patients with septicemia and concomitant endocarditis, meningitis, and arthritis (2). S. iniae was then considered as a disease of humans and aquatic mammals (3), is currently a potential zoonotic disease (4, 5), and is a major pathogen of fish worldwide (4, 6). In Brazil, S. iniae was initially associated with meningoencephalitis and septicemia in Nile tilapia (Oreochromis niloticus) from farms located within the state of Paraná, Southern Brazil in 2012 (7). Recently, we have isolated and identified this pathogen in diseased Nile tilapia from Southern Brazil that were reared in net cages within the Paranapanema River Basin, Northern Paraná, and with clinical manifestations of exophthalmos, erratic swimming, and melanosis (8). Consequently, this pathogen is of great concern in Brazil due to the direct impacts on the local fishing industry, the growing public health concerns worldwide, and primarily since this infectious disease agent is not a common pathogen associated with fish disease in this country. Therefore, the complete sequencing of this organism is fundamental to understanding aspects related to pathogenesis, infection, epidemiology, and immunity. The complete genome of S. iniae UEL-Si1 was sequenced using Illumina HiSeq/MiSeq, with the paired-end sequence strategy, which resulted in a total of 3,227,205 reads of high quality. The genome was assembled by de novo strategy with the software SPAdes version 3.9.0 (9). The assembly yielded 60 contigs and contains 2,395,193 bp, with a GC content of 36.3%. The RAST server program (10) proposed that this S. iniae genome contains 2,426 coding sequences from 329 subsystems. These include features associated with the metabolism for carbohydrates (n = 308); synthesis of amino acids and derivatives (n = 155); protein metabolism (n = 153); cell wall and capsule (n = 133); DNA metabolism (n = 114); RNA metabolism (n = 100); cofactors, vitamins, prosthetic groups, and pigments (n = 83); synthesis of fatty acids, lipids, and isoprenoids (n = 73); virulence, disease, and defense (n = 65); membrane transport (n = 51); phages, prophages, transposable elements, and plasmids (n = 46); stress response (n = 39); regulation and cell signaling (n = 38); phosphorus metabolism (n = 35); cell division and cell cycle (n = 32); iron acquisition and metabolism (n = 24); respiration (n = 15); potassium metabolism (n = 5); and motility and chemotaxis (n = 2).

Accession number(s).

This complete genome shotgun project of S. iniae was deposited at DDBJ/ENA/GenBank under the accession number MNAC00000000. The version described in this paper is the first version, MNAC01000000.
  8 in total

1.  Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group.

Authors:  M R Weinstein; M Litt; D A Kertesz; P Wyper; D Rose; M Coulter; A McGeer; R Facklam; C Ostach; B M Willey; A Borczyk; D E Low
Journal:  N Engl J Med       Date:  1997-08-28       Impact factor: 91.245

2.  QUAST: quality assessment tool for genome assemblies.

Authors:  Alexey Gurevich; Vladislav Saveliev; Nikolay Vyahhi; Glenn Tesler
Journal:  Bioinformatics       Date:  2013-02-19       Impact factor: 6.937

3.  Fatal septicemia caused by the zoonotic bacterium Streptococcus iniae during an outbreak in Caribbean reef fish.

Authors:  N D Keirstead; J W Brake; M J Griffin; I Halliday-Simmonds; M A Thrall; E Soto
Journal:  Vet Pathol       Date:  2013-09-27       Impact factor: 2.221

4.  Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method.

Authors:  S H Goh; D Driedger; S Gillett; D E Low; S M Hemmingsen; M Amos; D Chan; M Lovgren; B M Willey; C Shaw; J A Smith
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 5.  Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination.

Authors:  Wendy Agnew; Andrew C Barnes
Journal:  Vet Microbiol       Date:  2007-03-12       Impact factor: 3.293

Review 6.  Towards control of Streptococcus iniae.

Authors:  Justice C F Baiano; Andrew C Barnes
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

7.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

8.  Streptococcus iniae outbreaks in Brazilian Nile tilapia (Oreochromis niloticus L:) farms.

Authors:  H C P Figueiredo; L Nobrega Netto; C A G Leal; Ulisses P Pereira; Glaúcia F Mian
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.